Publications

Publications

Li ZD, Liu F, Zeng Y, Liu Y, Luo W, Yuan F, Li S, Li Q, Chen J, Fujita M, Zhang G, Li Y. EGCG suppresses PD-1 expression of T cells via inhibiting NF-κB phosphorylation and nuclear translocation. Int Immunopharmacol. 2024 May 30;133:112069. doi: 10.1016/j.intimp.2024.112069. Epub 2024 Apr 20. PubMed PMID: 38643710.

Hay ZLZ, Kim DD, Cimons JM, Knapp JR, Kohler ME, Quansah M, Zúñiga TM, Camp FA, Fujita M, Wang XJ, O'Connor BP, Slansky JE. Granzyme F: Exhaustion Marker and Modulator of Chimeric Antigen Receptor T Cell-Mediated Cytotoxicity. J Immunol. 2024 Apr 15;212(8):1381-1391. doi: 10.4049/jimmunol.2300334. PubMed PMID: 38416029; PubMed Central PMCID: PMC10984789.

Ravindran Menon D, Hammerlindl H, Gimenez G, Hammerlindl S, Zuegner E, Torrano J, Bordag N, Emran AA, Giam M, Denil S, Pavelka N, Tan AC, Sturm RA, Haass NK, Rancati G, Herlyn M, Magnes C, Eccles MR, Fujita M, Schaider H. H3K4me3 remodeling induced acquired resistance through O-GlcNAc transferase. Drug Resist Updat. 2023 Nov;71:100993. doi: 10.1016/j.drup.2023.100993. Epub 2023 Aug 10. PubMed PMID: 37639774; PubMed Central PMCID: PMC10719180.

Vaddi PK, Osborne DG, Nicklawsky A, Williams NK, Menon DR, Smith D, Mayer J, Reid A, Domenico J, Nguyen GH, Robinson WA, Ziman M, Gao D, Zhai Z, Fujita M. CTLA4 mRNA is downregulated by miR-155 in regulatory T cells, and reduced blood CTLA4 levels are associated with poor prognosis in metastatic melanoma patients. Front Immunol. 2023;14:1173035. doi: 10.3389/fimmu.2023.1173035. eCollection 2023. PubMed PMID: 37197667; PubMed Central PMCID: PMC10183574.

Zhai Z, Yamauchi T, Shangraw S, Hou V, Matsumoto A, Fujita M. Ethanol Metabolism and Melanoma. Cancers (Basel). 2023 Feb 16;15(4). doi: 10.3390/cancers15041258. Review. PubMed PMID: 36831600; PubMed Central PMCID: PMC9954650.

Yamauchi T, Shangraw S, Zhai Z, Ravindran Menon D, Batta N, Dellavalle RP, Fujita M. Alcohol as a Non-UV Social-Environmental Risk Factor for Melanoma. Cancers (Basel). 2022 Oct 13;14(20). doi: 10.3390/cancers14205010. Review. PubMed PMID: 36291794; PubMed Central PMCID: PMC9599745.

Osborne DG, Domenico J, Fujita M. Expression of IL-37 Induces a Regulatory T-Cell-like Phenotype and Function in Jurkat Cells. Cells. 2022 Aug 18;11(16). doi: 10.3390/cells11162565. PubMed PMID: 36010641; PubMed Central PMCID: PMC9406943.

Rundle CW, Rietcheck HR, Maghfour J, Dercon S, Fernandez J, Lio P, Dellavalle RP, Fujita M, Yardley H. Anti-inflammatory Effect of Cannabidiol and Palmitoylethanolamide Containing Topical Formulation on Skin in a 12- O -Tetradecanoylphorbol-13-Acetate-Induced Dermatitis Model in Mice. Dermatitis. 2022 Jul-Aug 01;33(4):277-281. doi: 10.1097/DER.0000000000000722. PubMed PMID: 33654018.

Mukherjee N, Dart CR, Amato CM, Honig-Frand A, Lambert JR, Lambert KA, Robinson WA, Tobin RP, McCarter MD, Couts KL, Fujita M, Norris DA, Shellman YG. Expression Differences in BCL2 Family Members between Uveal and Cutaneous Melanomas Account for Varying Sensitivity to BH3 Mimetics. J Invest Dermatol. 2022 Jul;142(7):1912-1922.e7. doi: 10.1016/j.jid.2021.11.035. Epub 2021 Dec 20. PubMed PMID: 34942200; PubMed Central PMCID: PMC9635014.

Bhatia S, Nguyen D, Darragh LB, Van Court B, Sharma J, Knitz MW, Piper M, Bukkapatnam S, Gadwa J, Bickett TE, Bhuvane S, Corbo S, Wu B, Lee Y, Fujita M, Joshi M, Heasley LE, Ferris RL, Rodriguez O, Albanese C, Kapoor M, Pasquale EB, Karam SD. EphB4 and ephrinB2 act in opposition in the head and neck tumor microenvironment. Nat Commun. 2022 Jun 20;13(1):3535. doi: 10.1038/s41467-022-31124-7. PubMed PMID: 35725568; PubMed Central PMCID: PMC9209511.

Li Y, Lofchy L, Wang G, Gaikwad H, Fujita M, Simberg D. PEGylated Liposomes Accumulate in the Areas Relevant to Skin Toxicities via Passive Extravasation across "Leaky" Endothelium. ACS Nano. 2022 Apr 26;16(4):6349-6358. doi: 10.1021/acsnano.2c00423. Epub 2022 Mar 28. PubMed PMID: 35343675; PubMed Central PMCID: PMC10472601.

Li H, Zhang C, Bian L, Deng H, Blevins M, Han G, Fan B, Yang C, Zhao R, High W, Norris D, Fujita M, Wang XJ, Huang M. Inhibition of CtBP-Regulated Proinflammatory Gene Transcription Attenuates Psoriatic Skin Inflammation. J Invest Dermatol. 2022 Feb;142(2):390-401. doi: 10.1016/j.jid.2021.06.029. Epub 2021 Jul 20. PubMed PMID: 34293351; PubMed Central PMCID: PMC8770725.

Vorwald VM, Davis DM, Van Gulick RJ, Torphy RJ, Borgers JS, Klarquist J, Couts KL, Amato CM, Cogswell DT, Fujita M, Castleman MJ, Davis T, Lozupone C, Medina TM, Robinson WA, Gapin L, McCarter MD, Tobin RP. Circulating CD8(+) mucosal-associated invariant T cells correlate with improved treatment responses and overall survival in anti-PD-1-treated melanoma patients. Clin Transl Immunology. 2022;11(1):e1367. doi: 10.1002/cti2.1367. eCollection 2022. PubMed PMID: 35028137; PubMed Central PMCID: PMC8743567.

Batta N, Shangraw S, Nicklawsky A, Yamauchi T, Zhai Z, Ravindran Menon D, Gao D, Dellavalle RP, Fujita M. Global melanoma correlations with obesity, smoking, and alcohol consumption. JMIR Dermatol. 2021 Jul-Dec;4(2):e31275. doi: 10.2196/31275. Epub 2021 Dec 13. PubMed PMID: 35990801; PubMed Central PMCID: PMC9387903.

Ravindran Menon D, Li Y, Yamauchi T, Osborne DG, Vaddi PK, Wempe MF, Zhai Z, Fujita M. EGCG Inhibits Tumor Growth in Melanoma by Targeting JAK-STAT Signaling and Its Downstream PD-L1/PD-L2-PD1 Axis in Tumors and Enhancing Cytotoxic T-Cell Responses. Pharmaceuticals (Basel). 2021 Oct 26;14(11). doi: 10.3390/ph14111081. PubMed PMID: 34832863; PubMed Central PMCID: PMC8618268.

Nassar KW, Hintzsche JD, Bagby SM, Espinoza V, Langouët-Astrié C, Amato CM, Chimed TS, Fujita M, Robinson W, Tan AC, Schweppe RE. Targeting CDK4/6 Represents a Therapeutic Vulnerability in Acquired BRAF/MEK Inhibitor-Resistant Melanoma. Mol Cancer Ther. 2021 Oct;20(10):2049-2060. doi: 10.1158/1535-7163.MCT-20-1126. Epub 2021 Aug 10. PubMed PMID: 34376578; PubMed Central PMCID: PMC9768695.

Tengesdal IW, Menon DR, Osborne DG, Neff CP, Powers NE, Gamboni F, Mauro AG, D'Alessandro A, Stefanoni D, Henen MA, Mills TS, De Graaf DM, Azam T, Vogeli B, Palmer BE, Pietras EM, DeGregori J, Tan AC, Joosten LAB, Fujita M, Dinarello CA, Marchetti C. Targeting tumor-derived NLRP3 reduces melanoma progression by limiting MDSCs expansion. Proc Natl Acad Sci U S A. 2021 Mar 9;118(10). doi: 10.1073/pnas.2000915118. PubMed PMID: 33649199; PubMed Central PMCID: PMC7958415.

Goldstein NB, Steel A, Barbulescu CC, Koster MI, Wright MJ, Jones KL, Gao B, Ward B, Woessner B, Trottier Z, Pakieser J, Hu J, Lambert KA, Shellman YG, Fujita M, Robinson WA, Roop DR, Norris DA, Birlea SA. Melanocyte Precursors in the Hair Follicle Bulge of Repigmented Vitiligo Skin Are Controlled by RHO-GTPase, KCTD10, and CTNNB1 Signaling. J Invest Dermatol. 2021 Mar;141(3):638-647.e13. doi: 10.1016/j.jid.2020.07.016. Epub 2020 Aug 13. PubMed PMID: 32800877.

de Graaf DM, Jaeger M, van den Munckhof ICL, Ter Horst R, Schraa K, Zwaag J, Kox M, Fujita M, Yamauchi T, Mercurio L, Madonna S, Rutten JHW, de Graaf J, Riksen NP, van de Veerdonk FL, Netea MG, Joosten LAB, Dinarello CA. Reduced concentrations of the B cell cytokine interleukin 38 are associated with cardiovascular disease risk in overweight subjects. Eur J Immunol. 2021 Mar;51(3):662-671. doi: 10.1002/eji.201948390. Epub 2020 Nov 19. PubMed PMID: 33125159; PubMed Central PMCID: PMC7983920.

Zhai Z, Vaddi PK, Samson JM, Takegami T, Fujita M. NLRP1 Functions Downstream of the MAPK/ERK Signaling via ATF4 and Contributes to Acquired Targeted Therapy Resistance in Human Metastatic Melanoma. Pharmaceuticals (Basel). 2020 Dec 30;14(1). doi: 10.3390/ph14010023. PubMed PMID: 33396632; PubMed Central PMCID: PMC7823742.

Maghfour J, Rietcheck HR, Rundle CW, Runion TM, Jafri ZA, Dercon S, Lio P, Fernandez J, Fujita M, Dellavalle RP, Yardley H. An Observational Study of the Application of a Topical Cannabinoid Gel on Sensitive Dry Skin. J Drugs Dermatol. 2020 Dec 1;19(12):1204-1208. doi: 10.36849/JDD.2020.5464. PubMed PMID: 33346512.

Samson JM, Ravindran Menon D, Vaddi PK, Kalani Williams N, Domenico J, Zhai Z, Backos DS, Fujita M. Computational Modeling of NLRP3 Identifies Enhanced ATP Binding and Multimerization in Cryopyrin-Associated Periodic Syndromes. Front Immunol. 2020;11:584364. doi: 10.3389/fimmu.2020.584364. eCollection 2020. PubMed PMID: 33329557; PubMed Central PMCID: PMC7711157.

Zhai Z, Samson JM, Yamauchi T, Vaddi PK, Matsumoto Y, Dinarello CA, Ravindran Menon D, Fujita M. Inflammasome Sensor NLRP1 Confers Acquired Drug Resistance to Temozolomide in Human Melanoma. Cancers (Basel). 2020 Sep 4;12(9). doi: 10.3390/cancers12092518. PubMed PMID: 32899791; PubMed Central PMCID: PMC7563249.

Mukherjee N, Amato CM, Skees J, Todd KJ, Lambert KA, Robinson WA, Van Gulick R, Weight RM, Dart CR, Tobin RP, McCarter MD, Fujita M, Norris DA, Shellman YG. Simultaneously Inhibiting BCL2 and MCL1 Is a Therapeutic Option for Patients with Advanced Melanoma. Cancers (Basel). 2020 Aug 5;12(8). doi: 10.3390/cancers12082182. PubMed PMID: 32764384; PubMed Central PMCID: PMC7464298.

Anwar A, Anwar H, Yamauchi T, Tseng R, Agarwal R, Horwitz LD, Zhai Z, Fujita M. Bucillamine Inhibits UVB-Induced MAPK Activation and Apoptosis in Human HaCaT Keratinocytes and SKH-1 Hairless Mouse Skin. Photochem Photobiol. 2020 Jul;96(4):870-876. doi: 10.1111/php.13228. Epub 2020 Apr 13. PubMed PMID: 32077107; PubMed Central PMCID: PMC7387142.

Mukherjee N, Skees J, Todd KJ, West DA, Lambert KA, Robinson WA, Amato CM, Couts KL, Van Gulick R, MacBeth M, Nassar K, Tan AC, Zhai Z, Fujita M, Bagby SM, Dart CR, Lambert JR, Norris DA, Shellman YG. MCL1 inhibitors S63845/MIK665 plus Navitoclax synergistically kill difficult-to-treat melanoma cells. Cell Death Dis. 2020 Jun 8;11(6):443. doi: 10.1038/s41419-020-2646-2. PubMed PMID: 32513939; PubMed Central PMCID: PMC7280535.

Ravindran Menon D, Hammerlindl H, Torrano J, Schaider H, Fujita M. Epigenetics and metabolism at the crossroads of stress-induced plasticity, stemness and therapeutic resistance in cancer. Theranostics. 2020;10(14):6261-6277. doi: 10.7150/thno.42523. eCollection 2020. Review. PubMed PMID: 32483452; PubMed Central PMCID: PMC7255038.

Leachman SA, Hornyak TJ, Barsh G, Bastian BC, Brash DE, Cleaver JE, Cooper CD, D'Orazio JA, Fujita M, Holmen SL, Indra AK, Kraemer KH, Le Poole IC, Lo RS, Lund AW, Manga P, Pavan WJ, Setaluri V, Stemwedel CE, Kulesz-Martin MF. Melanoma to Vitiligo: The Melanocyte in Biology & Medicine-Joint Montagna Symposium on the Biology of Skin/PanAmerican Society for Pigment Cell Research Annual Meeting. J Invest Dermatol. 2020 Feb;140(2):269-274. doi: 10.1016/j.jid.2019.03.1164. Epub 2019 Jul 23. PubMed PMID: 31348921; PubMed Central PMCID: PMC6981008.

Samson JM, Ravindran Menon D, Smith DE, Baird E, Kitano T, Gao D, Tan AC, Fujita M. Clinical implications of ALDH1A1 and ALDH1A3 mRNA expression in melanoma subtypes. Chem Biol Interact. 2019 Dec 1;314:108822. doi: 10.1016/j.cbi.2019.108822. Epub 2019 Sep 30. PubMed PMID: 31580832; PubMed Central PMCID: PMC6916670.

Osborne DG, Domenico J, Luo Y, Reid AL, Amato C, Zhai Z, Gao D, Ziman M, Dinarello CA, Robinson WA, Fujita M. Interleukin-37 is highly expressed in regulatory T cells of melanoma patients and enhanced by melanoma cell secretome. Mol Carcinog. 2019 Sep;58(9):1670-1679. doi: 10.1002/mc.23044. Epub 2019 May 16. PubMed PMID: 31099111; PubMed Central PMCID: PMC6692223.

Højen JF, Kristensen MLV, McKee AS, Wade MT, Azam T, Lunding LP, de Graaf DM, Swartzwelter BJ, Wegmann M, Tolstrup M, Beckman K, Fujita M, Fischer S, Dinarello CA. IL-1R3 blockade broadly attenuates the functions of six members of the IL-1 family, revealing their contribution to models of disease. Nat Immunol. 2019 Sep;20(9):1138-1149. doi: 10.1038/s41590-019-0467-1. Epub 2019 Aug 19. PubMed PMID: 31427775; PubMed Central PMCID: PMC6707854.

Kuprys PV, Tsukamoto H, Gao B, Jia L, McGowan J, Coopersmith CM, Moreno MC, Hulsebus H, Meena AS, Souza-Smith FM, Roper P, Foster MT, Raju SV, Marshall SA, Fujita M, Curtis BJ, Wyatt TA, Mandrekar P, Kovacs EJ, Choudhry MA. Summary of the 2018 Alcohol and Immunology Research Interest Group (AIRIG) meeting. Alcohol. 2019 Jun;77:11-18. doi: 10.1016/j.alcohol.2018.08.010. Epub 2018 Aug 24. Review. PubMed PMID: 30763905; PubMed Central PMCID: PMC6733262.

Menon DR, Fujita M. A state of stochastic cancer stemness through the CDK1-SOX2 axis. Oncotarget. 2019 Apr 5;10(27):2583-2585. doi: 10.18632/oncotarget.26819. eCollection 2019 Apr 5. PubMed PMID: 31080551; PubMed Central PMCID: PMC6498994.

Matsumoto A, Ito S, Wakamatsu K, Ichiba M, Vasiliou V, Akao C, Song BJ, Fujita M. Ethanol induces skin hyperpigmentation in mice with aldehyde dehydrogenase 2 deficiency. Chem Biol Interact. 2019 Apr 1;302:61-66. doi: 10.1016/j.cbi.2019.01.035. Epub 2019 Feb 2. PubMed PMID: 30721697.

Sarvi S, Crispin R, Lu Y, Zeng L, Hurley TD, Houston DR, von Kriegsheim A, Chen CH, Mochly-Rosen D, Ranzani M, Mathers ME, Xu X, Xu W, Adams DJ, Carragher NO, Fujita M, Schuchter L, Unciti-Broceta A, Brunton VG, Patton EE. ALDH1 Bio-activates Nifuroxazide to Eradicate ALDH(High) Melanoma-Initiating Cells. Cell Chem Biol. 2018 Dec 20;25(12):1456-1469.e6. doi: 10.1016/j.chembiol.2018.09.005. Epub 2018 Oct 4. PubMed PMID: 30293938; PubMed Central PMCID: PMC6309505.

Ravindran Menon D, Luo Y, Arcaroli JJ, Liu S, KrishnanKutty LN, Osborne DG, Li Y, Samson JM, Bagby S, Tan AC, Robinson WA, Messersmith WA, Fujita M. CDK1 Interacts with Sox2 and Promotes Tumor Initiation in Human Melanoma. Cancer Res. 2018 Dec 1;78(23):6561-6574. doi: 10.1158/0008-5472.CAN-18-0330. Epub 2018 Oct 8. PubMed PMID: 30297536; PubMed Central PMCID: PMC6279496.

Filipp FV, Birlea S, Bosenberg MW, Brash D, Cassidy PB, Chen S, D'Orazio JA, Fujita M, Goh BK, Herlyn M, Indra AK, Larue L, Leachman SA, Le Poole C, Liu-Smith F, Manga P, Montoliu L, Norris DA, Shellman Y, Smalley KSM, Spritz RA, Sturm RA, Swetter SM, Terzian T, Wakamatsu K, Weber JS, Box NF. Frontiers in pigment cell and melanoma research. Pigment Cell Melanoma Res. 2018 Nov;31(6):728-735. doi: 10.1111/pcmr.12728. Epub 2018 Oct 3. PubMed PMID: 30281213; PubMed Central PMCID: PMC6701837.

Armstrong AW, Chambers CJ, Maverakis E, Cheng MY, Dunnick CA, Chren MM, Gelfand JM, Wong DJ, Gibbons BM, Gibbons CM, Torres J, Steel AC, Wang EA, Clark CM, Singh S, Kornmehl HA, Wilken R, Florek AG, Ford AR, Ma C, Ehsani-Chimeh N, Boddu S, Fujita M, Young PM, Rivas-Sanchez C, Cornejo BI, Serna LC, Carlson ER, Lane CJ. Effectiveness of Online vs In-Person Care for Adults With Psoriasis: A Randomized Clinical Trial. JAMA Netw Open. 2018 Oct 5;1(6):e183062. doi: 10.1001/jamanetworkopen.2018.3062. PubMed PMID: 30646223; PubMed Central PMCID: PMC6324453.

Goldstein NB, Koster MI, Jones KL, Gao B, Hoaglin LG, Robinson SE, Wright MJ, Birlea SI, Luman A, Lambert KA, Shellman YG, Fujita M, Robinson WA, Roop DR, Norris DA, Birlea SA. Repigmentation of Human Vitiligo Skin by NBUVB Is Controlled by Transcription of GLI1 and Activation of the β-Catenin Pathway in the Hair Follicle Bulge Stem Cells. J Invest Dermatol. 2018 Mar;138(3):657-668. doi: 10.1016/j.jid.2017.09.040. Epub 2017 Oct 17. PubMed PMID: 29054607; PubMed Central PMCID: PMC6135256.

Mukherjee N, Lu Y, Almeida A, Lambert K, Shiau CW, Su JC, Luo Y, Fujita M, Robinson WA, Robinson SE, Norris DA, Shellman YG. Use of a MCL-1 inhibitor alone to de-bulk melanoma and in combination to kill melanoma initiating cells. Oncotarget. 2017 Jul 18;8(29):46801-46817. doi: 10.18632/oncotarget.8695. PubMed PMID: 27086916; PubMed Central PMCID: PMC5564524.

Zhai Z, Liu W, Kaur M, Luo Y, Domenico J, Samson JM, Shellman YG, Norris DA, Dinarello CA, Spritz RA, Fujita M. NLRP1 promotes tumor growth by enhancing inflammasome activation and suppressing apoptosis in metastatic melanoma. Oncogene. 2017 Jul 6;36(27):3820-3830. doi: 10.1038/onc.2017.26. Epub 2017 Mar 6. PubMed PMID: 28263976; PubMed Central PMCID: PMC5501746.

Li Y, Fujita M, Boraschi D. Endotoxin Contamination in Nanomaterials Leads to the Misinterpretation of Immunosafety Results. Front Immunol. 2017;8:472. doi: 10.3389/fimmu.2017.00472. eCollection 2017. PubMed PMID: 28533772; PubMed Central PMCID: PMC5420554.

Pearson DR, Fujita M, High WA. Fulminant Mycosis Fungoides with Tissue Eosinophilia: A Unique Presentation of Two Cases with Acro-Periorbital Ulceration and An Aggressive Clinical Course. J Mol Biomark Diagn. 2017 May;8(3). doi: 10.4172/2155-9929.1000337. Epub 2017 Mar 2. PubMed PMID: 28758048; PubMed Central PMCID: PMC5531183.

Mukherjee N, Almeida A, Partyka KA, Lu Y, Schwan JV, Lambert K, Rogers M, Robinson WA, Robinson SE, Applegate AJ, Amato CM, Luo Y, Fujita M, Norris DA, Shellman YG. Combining a GSI and BCL-2 inhibitor to overcome melanoma's resistance to current treatments. Oncotarget. 2016 Dec 20;7(51):84594-84607. doi: 10.18632/oncotarget.13141. PubMed PMID: 27829238; PubMed Central PMCID: PMC5356684.

Dinarello CA, Nold-Petry C, Nold M, Fujita M, Li S, Kim S, Bufler P. Suppression of innate inflammation and immunity by interleukin-37. Eur J Immunol. 2016 May;46(5):1067-81. doi: 10.1002/eji.201545828. Review. PubMed PMID: 27060871; PubMed Central PMCID: PMC5003108.

Hawkes JE, Nguyen GH, Fujita M, Florell SR, Callis Duffin K, Krueger GG, O'Connell RM. microRNAs in Psoriasis. J Invest Dermatol. 2016 Feb;136(2):365-371. doi: 10.1038/JID.2015.409. Review. PubMed PMID: 26802234.

Singh SP, Schwartz MP, Tokuda EY, Luo Y, Rogers RE, Fujita M, Ahn NG, Anseth KS. A synthetic modular approach for modeling the role of the 3D microenvironment in tumor progression. Sci Rep. 2015 Dec 7;5:17814. doi: 10.1038/srep17814. PubMed PMID: 26638791; PubMed Central PMCID: PMC4671067.

Mukherjee N, Schwan JV, Fujita M, Norris DA, Shellman YG. Alternative Treatments For Melanoma: Targeting BCL-2 Family Members to De-Bulk and Kill Cancer Stem Cells. J Invest Dermatol. 2015 Sep;135(9):2155-2161. doi: 10.1038/jid.2015.145. Epub 2015 May 7. Review. PubMed PMID: 25947358; PubMed Central PMCID: PMC4537369.

Snedecor ER, Sung CC, Moncayo A, Rothstein BE, Mockler DC, Tonnesen MG, Jones EC, Fujita M, Clark RA, Shroyer KR, Chen J. Loss of primary cilia in melanoma cells is likely independent of proliferation and cell cycle progression. J Invest Dermatol. 2015 May;135(5):1456-1458. doi: 10.1038/jid.2015.22. Epub 2015 Jan 28. PubMed PMID: 25629424; PubMed Central PMCID: PMC4402114.

Højen JF, Rasmussen TA, Andersen KL, Winckelmann AA, Laursen RR, Gunst JD, Møller HJ, Fujita M, Østergaard L, Søgaard OS, Dinarello CA, Tolstrup M. Interleukin-37 Expression Is Increased in Chronic HIV-1-Infected Individuals and Is Associated with Inflammation and the Size of the Total Viral Reservoir. Mol Med. 2015 Apr 14;21(1):337-45. doi: 10.2119/molmed.2015.00031. PubMed PMID: 25879630; PubMed Central PMCID: PMC4534469.

Mukherjee N, Reuland SN, Lu Y, Luo Y, Lambert K, Fujita M, Robinson WA, Robinson SE, Norris DA, Shellman YG. Combining a BCL2 inhibitor with the retinoid derivative fenretinide targets melanoma cells including melanoma initiating cells. J Invest Dermatol. 2015 Mar;135(3):842-850. doi: 10.1038/jid.2014.464. Epub 2014 Oct 28. PubMed PMID: 25350317; PubMed Central PMCID: PMC4323853.

Chen HM, Fujita M. IL-37: a new player in immune tolerance. Cytokine. 2015 Mar;72(1):113-4. doi: 10.1016/j.cyto.2014.11.025. Epub 2015 Jan 12. PubMed PMID: 25592113.

Li S, Neff CP, Barber K, Hong J, Luo Y, Azam T, Palmer BE, Fujita M, Garlanda C, Mantovani A, Kim S, Dinarello CA. Extracellular forms of IL-37 inhibit innate inflammation in vitro and in vivo but require the IL-1 family decoy receptor IL-1R8. Proc Natl Acad Sci U S A. 2015 Feb 24;112(8):2497-502. doi: 10.1073/pnas.1424626112. Epub 2015 Feb 5. PubMed PMID: 25654981; PubMed Central PMCID: PMC4345608.

Nguyen N, Couts KL, Luo Y, Fujita M. Understanding melanoma stem cells. Melanoma Manag. 2015;2(2):179-188. doi: 10.2217/mmt.15.4. PubMed PMID: 26594315; PubMed Central PMCID: PMC4649940.

Luo Y, Cai X, Liu S, Wang S, Nold-Petry CA, Nold MF, Bufler P, Norris D, Dinarello CA, Fujita M. Suppression of antigen-specific adaptive immunity by IL-37 via induction of tolerogenic dendritic cells. Proc Natl Acad Sci U S A. 2014 Oct 21;111(42):15178-83. doi: 10.1073/pnas.1416714111. Epub 2014 Oct 7. PubMed PMID: 25294929; PubMed Central PMCID: PMC4210310.

Luo Y, Nguyen N, Fujita M. Isolation of human melanoma stem cells using ALDH as a marker. Curr Protoc Stem Cell Biol. 2013 Sep 20;26:3.8.1-3.8.10. doi: 10.1002/9780470151808.sc0308s26. PubMed PMID: 24510792; PubMed Central PMCID: PMC4164114.

Vasiliou V, Thompson DC, Smith C, Fujita M, Chen Y. Aldehyde dehydrogenases: from eye crystallins to metabolic disease and cancer stem cells. Chem Biol Interact. 2013 Feb 25;202(1-3):2-10. doi: 10.1016/j.cbi.2012.10.026. Epub 2012 Nov 16. Review. PubMed PMID: 23159885; PubMed Central PMCID: PMC4128326.

Liu W, Luo Y, Dunn JH, Norris DA, Dinarello CA, Fujita M. Dual role of apoptosis-associated speck-like protein containing a CARD (ASC) in tumorigenesis of human melanoma. J Invest Dermatol. 2013 Feb;133(2):518-27. doi: 10.1038/jid.2012.317. Epub 2012 Aug 30. PubMed PMID: 22931929; PubMed Central PMCID: PMC3511638.

Nguyen N, Luo Y, Fujita M. Aldehyde dehydrogenase isozymes: markers of cancer stem cells in human melanoma. Expert Rev Dermatol. 2013;8(2):111-113. doi: 10.1586/edm.13.2. PubMed PMID: 26877760; PubMed Central PMCID: PMC4749134.

Edwards CK 3rd, Green JS, Volk HD, Schiff M, Kotzin BL, Mitsuya H, Kawaguchi T, Sakata KM, Cheronis J, Trollinger D, Bankaitis-Davis D, Dinarello CA, Norris DA, Bevilacqua MP, Fujita M, Burmester GR. Combined anti-tumor necrosis factor-α therapy and DMARD therapy in rheumatoid arthritis patients reduces inflammatory gene expression in whole blood compared to DMARD therapy alone. Front Immunol. 2012;3:366. doi: 10.3389/fimmu.2012.00366. eCollection 2012. PubMed PMID: 23264777; PubMed Central PMCID: PMC3525111.

Luo Y, Ellis LZ, Dallaglio K, Takeda M, Robinson WA, Robinson SE, Liu W, Lewis KD, McCarter MD, Gonzalez R, Norris DA, Roop DR, Spritz RA, Ahn NG, Fujita M. Side population cells from human melanoma tumors reveal diverse mechanisms for chemoresistance. J Invest Dermatol. 2012 Oct;132(10):2440-2450. doi: 10.1038/jid.2012.161. Epub 2012 May 24. PubMed PMID: 22622430; PubMed Central PMCID: PMC3434242.

Luo Y, Dallaglio K, Chen Y, Robinson WA, Robinson SE, McCarter MD, Wang J, Gonzalez R, Thompson DC, Norris DA, Roop DR, Vasiliou V, Fujita M. ALDH1A isozymes are markers of human melanoma stem cells and potential therapeutic targets. Stem Cells. 2012 Oct;30(10):2100-13. doi: 10.1002/stem.1193. PubMed PMID: 22887839; PubMed Central PMCID: PMC3448863.

Reuland SN, Goldstein NB, Partyka KA, Smith S, Luo Y, Fujita M, Gonzalez R, Lewis K, Norris DA, Shellman YG. ABT-737 synergizes with Bortezomib to kill melanoma cells. Biol Open. 2012 Feb 15;1(2):92-100. doi: 10.1242/bio.2011035. Epub 2011 Nov 16. PubMed PMID: 23213401; PubMed Central PMCID: PMC3507205.

Domenico J, Lucas JJ, Fujita M, Gelfand EW. Susceptibility to vaccinia virus infection and spread in mice is determined by age at infection, allergen sensitization and mast cell status. Int Arch Allergy Immunol. 2012;158(2):196-205. doi: 10.1159/000330647. Epub 2012 Jan 26. PubMed PMID: 22286752; PubMed Central PMCID: PMC3291886.

Dunn JH, Ellis LZ, Fujita M. Inflammasomes as molecular mediators of inflammation and cancer: potential role in melanoma. Cancer Lett. 2012 Jan 1;314(1):24-33. doi: 10.1016/j.canlet.2011.10.001. Epub 2011 Oct 12. Review. PubMed PMID: 22050907.

Jensen JD, Dunn JH, Luo Y, Liu W, Fujita M, Dellavalle RP. Ellagic acid inhibits melanoma growth in vitro. Dermatol Reports. 2011 Oct 5;3(3):e36. doi: 10.4081/dr.2011.e36. eCollection 2011 Oct 5. PubMed PMID: 25386288; PubMed Central PMCID: PMC4211504.

Ellis LZ, Liu W, Luo Y, Okamoto M, Qu D, Dunn JH, Fujita M. Green tea polyphenol epigallocatechin-3-gallate suppresses melanoma growth by inhibiting inflammasome and IL-1β secretion. Biochem Biophys Res Commun. 2011 Oct 28;414(3):551-6. doi: 10.1016/j.bbrc.2011.09.115. Epub 2011 Oct 1. PubMed PMID: 21982776; PubMed Central PMCID: PMC3430966.

Reuland SN, Goldstein NB, Partyka KA, Cooper DA, Fujita M, Norris DA, Shellman YG. The combination of BH3-mimetic ABT-737 with the alkylating agent temozolomide induces strong synergistic killing of melanoma cells independent of p53. PLoS One. 2011;6(8):e24294. doi: 10.1371/journal.pone.0024294. Epub 2011 Aug 29. PubMed PMID: 21897876; PubMed Central PMCID: PMC3163662.

Tanaka A, Jensen JD, Prado R, Riemann H, Shellman YG, Norris DA, Chin L, Yee C, Fujita M. Whole recombinant yeast vaccine induces antitumor immunity and improves survival in a genetically engineered mouse model of melanoma. Gene Ther. 2011 Aug;18(8):827-34. doi: 10.1038/gt.2011.28. Epub 2011 Mar 10. PubMed PMID: 21390072; PubMed Central PMCID: PMC4596232.

Prado R, Jensen JD, Okamoto M, Luo Y, Lewis KD, Fujita M. Metastatic melanoma manifesting with purulent nodules composed of neutrophils and melanoma cells. Eur J Dermatol. 2011 Jul-Aug;21(4):642-3. doi: 10.1684/ejd.2011.1415. PubMed PMID: 21840791.

Luo Y, Robinson S, Fujita J, Siconolfi L, Magidson J, Edwards CK, Wassmann K, Storm K, Norris DA, Bankaitis-Davis D, Robinson WA, Fujita M. Transcriptome profiling of whole blood cells identifies PLEK2 and C1QB in human melanoma. PLoS One. 2011;6(6):e20971. doi: 10.1371/journal.pone.0020971. Epub 2011 Jun 15. PubMed PMID: 21698244; PubMed Central PMCID: PMC3115966.

Anwar A, Norris DA, Fujita M. Ubiquitin proteasomal pathway mediated degradation of p53 in melanoma. Arch Biochem Biophys. 2011 Apr 15;508(2):198-203. doi: 10.1016/j.abb.2010.12.012. Epub 2010 Dec 15. PubMed PMID: 21167122; PubMed Central PMCID: PMC3060965.

Prado R, Brice SL, Fukuda S, Hashimoto T, Fujita M. Paraneoplastic pemphigus herpetiformis with IgG antibodies to desmoglein 3 and without mucosal lesions. Arch Dermatol. 2011 Jan;147(1):67-71. doi: 10.1001/archdermatol.2010.362. PubMed PMID: 21242397.

Jensen JD, Fujita M, Dellavalle RP. Validation of psoriasis clinical severity and outcome measures: searching for a gold standard. Arch Dermatol. 2011 Jan;147(1):95-8. doi: 10.1001/archdermatol.2010.242. Epub 2010 Sep 20. PubMed PMID: 20855674.

Wang X, Fujita M, Prado R, Tousson A, Hsu HC, Schottelius A, Kelly DR, Yang PA, Wu Q, Chen J, Xu H, Elmets CA, Mountz JD, Edwards CK 3rd. Visualizing CD4 T-cell migration into inflamed skin and its inhibition by CCR4/CCR10 blockades using in vivo imaging model. Br J Dermatol. 2010 Mar;162(3):487-96. doi: 10.1111/j.1365-2133.2009.09552.x. Epub 2009 Oct 15. PubMed PMID: 19832835; PubMed Central PMCID: PMC3037861.

Strahan JE, Chorny JA, Cohen JL, Fujita M. Combined multifocal indeterminate cell histiocytosis and basal cell carcinoma. Arch Dermatol. 2010 Mar;146(3):346-7. doi: 10.1001/archdermatol.2010.13. PubMed PMID: 20231516.

Okamoto M, Liu W, Luo Y, Tanaka A, Cai X, Norris DA, Dinarello CA, Fujita M. Constitutively active inflammasome in human melanoma cells mediating autoinflammation via caspase-1 processing and secretion of interleukin-1beta. J Biol Chem. 2010 Feb 26;285(9):6477-88. doi: 10.1074/jbc.M109.064907. Epub 2009 Dec 28. PubMed PMID: 20038581; PubMed Central PMCID: PMC2825443.

Strahan JE, Fujita M. A violaceous nodule on the knee. Merkel cell carcinoma (MCC). Arch Dermatol. 2009 Jun;145(6):715-20. doi: 10.1001/archdermatol.2009.111-a. PubMed PMID: 19528432.

Miller LA, Goldstein NB, Johannes WU, Walton CH, Fujita M, Norris DA, Shellman YG. BH3 mimetic ABT-737 and a proteasome inhibitor synergistically kill melanomas through Noxa-dependent apoptosis. J Invest Dermatol. 2009 Apr;129(4):964-71. doi: 10.1038/jid.2008.327. Epub 2008 Nov 6. PubMed PMID: 18987671.

Fujita M, High WA, Asgari S, Lewis KD, Gonzalez R. Development of vitiligo during melanoma treatment with a novel survivin inhibitor: a case report and review of the literature. Int J Dermatol. 2009 Apr;48(4):426-30. doi: 10.1111/j.1365-4632.2009.03987.x. PubMed PMID: 19335434.

Goldstein NB, Johannes WU, Gadeliya AV, Green MR, Fujita M, Norris DA, Shellman YG. Active N-Ras and B-Raf inhibit anoikis by downregulating Bim expression in melanocytic cells. J Invest Dermatol. 2009 Feb;129(2):432-7. doi: 10.1038/jid.2008.227. Epub 2008 Jul 31. PubMed PMID: 18668139.

Usui ML, Mansbridge JN, Carter WG, Fujita M, Olerud JE. Keratinocyte migration, proliferation, and differentiation in chronic ulcers from patients with diabetes and normal wounds. J Histochem Cytochem. 2008 Jul;56(7):687-96. doi: 10.1369/jhc.2008.951194. Epub 2008 Apr 14. PubMed PMID: 18413645; PubMed Central PMCID: PMC2430161.

Anwar A, Gu M, Brady S, Qamar L, Behbakht K, Shellman YG, Agarwal R, Norris DA, Horwitz LD, Fujita M. Photoprotective effects of bucillamine against UV-induced damage in an SKH-1 hairless mouse model. Photochem Photobiol. 2008 Mar-Apr;84(2):477-83. doi: 10.1111/j.1751-1097.2007.00288.x. Epub 2008 Feb 7. PubMed PMID: 18266821.

Riemann H, Takao J, Shellman YG, Hines WA, Edwards CK 3rd, Franzusoff A, Norris DA, Fujita M. Generation of a prophylactic melanoma vaccine using whole recombinant yeast expressing MART-1. Exp Dermatol. 2007 Oct;16(10):814-22. doi: 10.1111/j.1600-0625.2007.00599.x. PubMed PMID: 17845213.

Riemann H, Loser K, Beissert S, Fujita M, Schwarz A, Schwarz T, Grabbe S. IL-12 breaks dinitrothiocyanobenzene (DNTB)-mediated tolerance and converts the tolerogen DNTB into an immunogen. J Immunol. 2005 Nov 1;175(9):5866-74. doi: 10.4049/jimmunol.175.9.5866. PubMed PMID: 16237079.

Shellman YG, Park YL, Marr DG, Casper K, Xu Y, Fujita M, Swerlick R, Norris DA. Release of vascular endothelial growth factor from a human melanoma cell line, WM35, is induced by hypoxia but not ultraviolet radiation and is potentiated by activated Ras mutation. J Invest Dermatol. 2003 Oct;121(4):910-7. doi: 10.1046/j.1523-1747.2003.12511.x. PubMed PMID: 14632212.

Fujita M, Darmstadt GL, Dinulos JG. Cutis marmorata telangiectatica congenita with hemangiomatous histopathologic features. J Am Acad Dermatol. 2003 Jun;48(6):950-4. doi: 10.1067/mjd.2003.301. PubMed PMID: 12789192.

Khlgatian MK, Hadshiew IM, Asawanonda P, Yaar M, Eller MS, Fujita M, Norris DA, Gilchrest BA. Tyrosinase gene expression is regulated by p53. J Invest Dermatol. 2002 Jan;118(1):126-32. doi: 10.1046/j.0022-202x.2001.01667.x. PubMed PMID: 11851885.

Fujita M, Mann T, Mann O, Berg D. Surgical pearl: use of nerve blocks for botulinum toxin treatment of palmar-plantar hyperhidrosis. J Am Acad Dermatol. 2001 Oct;45(4):587-9. doi: 10.1067/mjd.2001.116341. PubMed PMID: 11568751.

Shellman YG, Chapman JT, Fujita M, Norris DA, Maxwell IH. Expression of activated N-ras in a primary melanoma cell line counteracts growth inhibition by transforming growth factor-beta. J Invest Dermatol. 2000 Jun;114(6):1200-4. doi: 10.1046/j.1523-1747.2000.00988.x. PubMed PMID: 10844567.

Fujita M, Norris DA, Yagi H, Walsh P, Morelli JG, Weston WL, Terada N, Bennion SD, Robinson W, Lemon M, Maxwell IH, Yohn JJ. Overexpression of mutant ras in human melanoma increases invasiveness, proliferation and anchorage-independent growth in vitro and induces tumour formation and cachexia in vivo. Melanoma Res. 1999 Jun;9(3):279-91. doi: 10.1097/00008390-199906000-00010. PubMed PMID: 10465584.

Furukawa F, Fujii K, Horiguchi Y, Matsuyoshi N, Fujita M, Toda K, Imamura S, Wakita H, Shirahama S, Takigawa M. Roles of E- and P-cadherin in the human skin. Microsc Res Tech. 1997 Aug 15;38(4):343-52. doi: 10.1002/(SICI)1097-0029(19970815)38:4<343::AID-JEMT2>3.0.CO;2-K. Review. PubMed PMID: 9297684.

Sugiyama H, Papst P, Fujita M, Gelfand EW, Terada N. Overexpression of wild type p70 S6 kinase interferes with cytokinesis. Oncogene. 1997 Jul 24;15(4):443-52. doi: 10.1038/sj.onc.1201207. PubMed PMID: 9242381.

Seline PC, Norris DA, Horikawa T, Fujita M, Middleton MH, Morelli JG. Expression of E and P-cadherin by melanoma cells decreases in progressive melanomas and following ultraviolet radiation. J Invest Dermatol. 1996 Jun;106(6):1320-4. doi: 10.1111/1523-1747.ep12349048. PubMed PMID: 8752677.

Ohta K, Furukawa F, Fujita M, Kashihara-Sawami M, Horiguchi Y, Ueda M, Kurokawa S, Takigawa M, Imamura S. Evaluation of sialyl Lewisx antigen in the skin and the sera of patients with psoriasis vulgaris. J Dermatol. 1996 Feb;23(2):95-9. doi: 10.1111/j.1346-8138.1996.tb03977.x. PubMed PMID: 8839235.

Furukawa F, Takigawa M, Matsuyoshi N, Shirahama S, Wakita H, Fujita M, Horiguchi Y, Imamura S. Cadherins in cutaneous biology. J Dermatol. 1994 Nov;21(11):802-13. doi: 10.1111/j.1346-8138.1994.tb03294.x. Review. PubMed PMID: 7852640.

Horiguchi Y, Furukawa F, Fujita M, Imamura S. Ultrastructural localization of E-cadherin cell adhesion molecule on the cytoplasmic membrane of keratinocytes in vivo and in vitro. J Histochem Cytochem. 1994 Oct;42(10):1333-40. doi: 10.1177/42.10.7930515. PubMed PMID: 7930515.

Ikai K, Ogino A, Ozaki M, Fujita M, Today K, Imamura S. Eosinophil cationic protein in atopic dermatitis: changes of serum levels by the anti‐allergic agent ketotifen. Journal of the European Academy of Dermatology and Venereology. 1994 January; 3:59-62. doi: https://doi.org/10.1111/j.1468-3083.1994.tb00072.x.

Fujita M, Miyachi Y, Furukawa F, Toichi E, Furukawa I, Nakajima N, Imamura S. A case of cutaneous T-cell lymphoma expressing gamma delta T-cell receptors. J Am Acad Dermatol. 1993 Feb;28(2 Pt 2):355-60. doi: 10.1016/0190-9622(93)70054-w. PubMed PMID: 8436658.

Fujita M, Miyachi Y, Nakata K, Imamura S. gamma delta T-cell receptor-positive cells of human skin. II. Appearance in delayed-type hypersensitivity reaction. Arch Dermatol Res. 1993;285(7):436-40. doi: 10.1007/BF00372140. PubMed PMID: 8304785.

Fujita M, Miyachi Y, Nakata K, Imamura S. Gamma delta T-cell receptor-positive cells in human skin. I. Incidence and V-region gene expression in granulomatous skin lesions. J Am Acad Dermatol. 1993 Jan;28(1):46-50. doi: 10.1016/0190-9622(93)70007-g. PubMed PMID: 8425969.

Fujita M, Miyachi Y, Nakata K, Imamura S. Appearance of gamma delta T cell receptor-positive cells following alpha beta T cell receptor-positive cells in the lepromin reaction of human skin. Immunol Lett. 1993 Jan;35(1):39-44. doi: 10.1016/0165-2478(93)90145-r. PubMed PMID: 8458635.

Imamura S, Horio T, Yanase K, Taniguchi S, Miyachi Y, Tachibana T, Yoshioka A, Fujita M. Erythema multiforme: pathomechanism of papular erythema and target lesion. J Dermatol. 1992 Sep;19(9):524-33. doi: 10.1111/j.1346-8138.1992.tb03723.x. Review. PubMed PMID: 1282527.

Fujita M. Does follicular mucinosis in Hodgkin's disease represent a sign of poor prognosis?. J Am Acad Dermatol. 1992 Apr;26(4):659-60. doi: 10.1016/s0190-9622(08)80808-0. PubMed PMID: 1534569.

Furukawa F, Imamura S, Fujita M, Kinoshita K, Yoshitake K, Brown WR, Norris DA. Immunohistochemical localization of proliferating cell nuclear antigen/cyclin in human skin. Arch Dermatol Res. 1992;284(2):86-91. doi: 10.1007/BF00373375. PubMed PMID: 1351713.

Fujita M, Furukawa F, Fujii K, Horiguchi Y, Takeichi M, Imamura S. Expression of cadherin cell adhesion molecules during human skin development: morphogenesis of epidermis, hair follicles and eccrine sweat ducts. Arch Dermatol Res. 1992;284(3):159-66. doi: 10.1007/BF00372710. PubMed PMID: 1503501.

Fujita M, Ohno S, Danno K, Miyachi Y. Two cases of diaper area granuloma of the adult. J Dermatol. 1991 Nov;18(11):671-5. doi: 10.1111/j.1346-8138.1991.tb03154.x. PubMed PMID: 1800534.

Fujita M, Horiguchi Y, Miyachi Y, Furukawa F, Kashihara-Sawami M, Imamura S. A subpopulation of Langerhans cells (CD1a+Lag-) increased in the dermis of plaque lesions of mycosis fungoides. J Am Acad Dermatol. 1991 Sep;25(3):491-9. doi: 10.1016/0190-9622(91)70229-u. PubMed PMID: 1717524.

Fujita M, Furukawa F, Horiguchi Y, Ueda M, Kashihara-Sawami M, Imamura S. Regional development of Langerhans cells and formation of Birbeck granules in human embryonic and fetal skin. J Invest Dermatol. 1991 Jul;97(1):65-72. doi: 10.1111/1523-1747.ep12478115. PubMed PMID: 1711549.

Fujita M, Miyachi Y, Izumi S, Ishida H, Obara A, Imamura S. Immunohistochemical study of lepromin reaction in healthy adults. J Dermatol Sci. 1991 May;2(3):179-82. doi: 10.1016/0923-1811(91)90065-6. PubMed PMID: 1878346.

Dosaka N, Tanaka T, Takahashi K, Miyazaki M, Fujita M, Miyachi Y, Imamura S. Follow-up study of a cutaneous adult T-cell leukemia/lymphoma patient by southern blot analysis. Arch Dermatol. 1990 Nov;126(11):1521-2. PubMed PMID: 2241213.

Fujita M, Miyachi Y, Horio T, Imamura S. Immunohistochemical comparison of actinic reticuloid with allergic contact dermatitis. J Dermatol Sci. 1990 Jul;1(4):289-96. doi: 10.1016/0923-1811(90)90122-t. PubMed PMID: 1710141.

Fujita M, Kashihara-Sawami M, Horiguchi Y, Furukawa F, Ueda M, Imamura S. Langerhans cells in human allergic contact dermatitis contain varying numbers of Birbeck granules. Double staining immunohistochemistry with OKT6 and Lag antibody. Histochemistry. 1990;94(5):497-504. doi: 10.1007/BF00272613. PubMed PMID: 2283313.

Dosaka N, Tanaka T, Fujita M, Miyachi Y, Horio T, Imamura S. Southern blot analysis of clonal rearrangements of T-cell receptor gene in plaque lesion of mycosis fungoides. J Invest Dermatol. 1989 Nov;93(5):626-9. doi: 10.1111/1523-1747.ep12319746. PubMed PMID: 2551970.

Matsuyoshi N, Horiguchi Y, Tanaka T, Takahashi K, Dosaka N, Fujita M, Miyachi Y, Imamura S. Lymphomatoid papulosis: ultrastructural, immunohistochemical and gene analytical studies. Br J Dermatol. 1989 Sep;121(3):381-9. doi: 10.1111/j.1365-2133.1989.tb01433.x. PubMed PMID: 2679857.

Yamasaki T, Kikuchi H, Yamashita J, Asato R, Fujita M. Primary spinal intramedullary malignant melanoma: case report. Neurosurgery. 1989 Jul;25(1):117-21. doi: 10.1097/00006123-198907000-00023. PubMed PMID: 2755570.

Dosaka N, Fujita M, Tanaka T, Miyachi Y, Imamura S. Analysis of epidermal growth factor receptor gene in psoriasis. J Dermatol. 1989 Jun;16(3):184-6. doi: 10.1111/j.1346-8138.1989.tb01246.x. PubMed PMID: 2794219.

Takahashi K, Tanaka T, Fujita M, Horiguchi Y, Miyachi Y, Imamura S. Cutaneous-type adult T-cell leukemia/lymphoma. A unique clinical feature with monoclonal T-cell proliferation detected by Southern blot analysis. Arch Dermatol. 1988 Mar;124(3):399-404. doi: 10.1001/archderm.124.3.399. PubMed PMID: 2894203.

Ideyama S, Tanaka T, Akagi M, Horiguchi Y, Miyachi Y, Imamura S. A case of a lymphoproliferative disorder: usefulness of DNA analysis in diagnosis. Br J Dermatol. 1988 Feb;118(2):261-6. doi: 10.1111/j.1365-2133.1988.tb01784.x. PubMed PMID: 2831931.

Akagi M, Taniguchi S, Ozaki M, Imamura S, Kitaichi M, Matsui Y, Ohshima Y. Necrobiosis-lipoidica-like skin manifestation in lymphomatoid granulomatosis (Liebow). Dermatologica. 1987;174(2):84-92. doi: 10.1159/000248989. PubMed PMID: 3556699.

NLRP1 Functions Downstream of the MAPK/ERK Signaling via ATF4 and Contributes to Acquired Targeted Therapy Resistance in Human Metastatic Melanoma. Pharmaceuticals (Basel, Switzerland). . NIHMSID: NIHMS1666260.